149 related articles for article (PubMed ID: 35474364)
1. Correcting for discounting and loss aversion in composite time trade-off.
Lipman SA; Attema AE; Versteegh MM
Health Econ; 2022 Aug; 31(8):1633-1648. PubMed ID: 35474364
[TBL] [Abstract][Full Text] [Related]
2. Modifying the Composite Time Trade-Off Method to Improve Its Discriminatory Power.
Jakubczyk M; Lipman SA; Roudijk B; Norman R; Pullenayegum E; Yang Y; Gu NY; Stolk E
Value Health; 2023 Feb; 26(2):280-291. PubMed ID: 36244905
[TBL] [Abstract][Full Text] [Related]
3. The effect of duration and time preference on the gap between adult and child health state valuations in time trade-off.
Lang Z; Attema AE; Lipman SA
Eur J Health Econ; 2024 Jun; 25(4):601-613. PubMed ID: 37420133
[TBL] [Abstract][Full Text] [Related]
4. Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology.
Lipman SA; Zhang L; Shah KK; Attema AE
Eur J Health Econ; 2023 Mar; 24(2):293-305. PubMed ID: 35596831
[TBL] [Abstract][Full Text] [Related]
5. A threshold explanation for the lack of variation in negative composite time trade-off values.
Roudijk B; Donders R; Stalmeier P
Qual Life Res; 2022 Sep; 31(9):2753-2761. PubMed ID: 35622295
[TBL] [Abstract][Full Text] [Related]
6. Re-revisiting the Utilities of Health States Worse than Dead: The Problem Remains.
Jakubczyk M
Med Decis Making; 2023; 43(7-8):875-885. PubMed ID: 37846095
[TBL] [Abstract][Full Text] [Related]
7. Deriving time discounting correction factors for TTO tariffs.
Attema AE; Brouwer WB
Health Econ; 2014 Apr; 23(4):410-25. PubMed ID: 23564665
[TBL] [Abstract][Full Text] [Related]
8. A Head-On Ordinal Comparison of the Composite Time Trade-Off and the Better-Than-Dead Method.
Roudijk B; Donders ART; Stalmeier PFM
Value Health; 2020 Feb; 23(2):236-241. PubMed ID: 32113629
[TBL] [Abstract][Full Text] [Related]
9. How different are composite and traditional TTO valuations of severe EQ-5D-5L states?
Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA
Qual Life Res; 2016 Aug; 25(8):2101-8. PubMed ID: 26875190
[TBL] [Abstract][Full Text] [Related]
10. A consistency test of the time trade-off.
Bleichrodt H; Pinto JL; Abellan-Perpiñan JM
J Health Econ; 2003 Nov; 22(6):1037-52. PubMed ID: 14604559
[TBL] [Abstract][Full Text] [Related]
11. Health State Utilities for Acute Myeloid Leukaemia: A Time Trade-off Study.
Joshi N; Hensen M; Patel S; Xu W; Lasch K; Stolk E
Pharmacoeconomics; 2019 Jan; 37(1):85-92. PubMed ID: 30136178
[TBL] [Abstract][Full Text] [Related]
12. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
Bleichrodt H
Health Econ; 2002 Jul; 11(5):447-56. PubMed ID: 12112493
[TBL] [Abstract][Full Text] [Related]
13. Health state utilities for beta-thalassemia: a time trade-off study.
Martin AP; Ferri Grazzi E; Mighiu C; Chevli M; Shah F; Maher L; Shaikh A; Sagar A; Hubberstey H; Franks B; Ramos-Goñi JM; Oppe M; Tang D
Eur J Health Econ; 2023 Feb; 24(1):27-38. PubMed ID: 35347553
[TBL] [Abstract][Full Text] [Related]
14. A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada.
Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA;
Med Care; 2016 Jan; 54(1):98-105. PubMed ID: 26492214
[TBL] [Abstract][Full Text] [Related]
15. Is it worth it? Greater risk aversion with lower life satisfaction among depressed individuals.
Young BE; Goodmann DR; Hamlin E; Tabaczyk O; Dunn LB; Muñoz RF; Leykin Y
Psychol Health Med; 2024 Apr; 29(4):732-742. PubMed ID: 38525913
[TBL] [Abstract][Full Text] [Related]
16. Elicitation of health state utilities associated with differing durations of morning stiffness in rheumatoid arthritis.
Iqbal I; Dasgupta B; Taylor P; Heron L; Pilling C
J Med Econ; 2012; 15(6):1192-200. PubMed ID: 22804691
[TBL] [Abstract][Full Text] [Related]
17. Assessing the preferences of patients with psoriasis. A quantitative, utility approach.
Zug KA; Littenberg B; Baughman RD; Kneeland T; Nease RF; Sumner W; O'Connor GT; Jones R; Morrison E; Cimis R
Arch Dermatol; 1995 May; 131(5):561-8. PubMed ID: 7741543
[TBL] [Abstract][Full Text] [Related]
18. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.
Rencz F; Brodszky V; Gulácsi L; Golicki D; Ruzsa G; Pickard AS; Law EH; Péntek M
Value Health; 2020 Sep; 23(9):1235-1245. PubMed ID: 32940242
[TBL] [Abstract][Full Text] [Related]
19. United States Valuation of EQ-5D-5L Health States Using an International Protocol.
Pickard AS; Law EH; Jiang R; Pullenayegum E; Shaw JW; Xie F; Oppe M; Boye KS; Chapman RH; Gong CL; Balch A; Busschbach JJV
Value Health; 2019 Aug; 22(8):931-941. PubMed ID: 31426935
[TBL] [Abstract][Full Text] [Related]
20. Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments.
Augustovski F; Belizán M; Gibbons L; Reyes N; Stolk E; Craig BM; Tejada RA
Value Health; 2020 Jul; 23(7):880-888. PubMed ID: 32762989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
